Costs for lifesaving drugs have skyrocketed. Experts say ‘over-patenting’ to prevent generic competition is part of the problem Costs for lifesaving drugs have skyrocketed. Experts say ‘over-patenting’ to prevent generic competition is part of the problem – I-MAK

Costs for lifesaving drugs have skyrocketed. Experts say ‘over-patenting’ to prevent generic competition is part of the problem

Media Article 30 Apr 2019

Partner with us now to build
a more just and equitable
medicine system for all.